| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 11/05/2003 | CN1126818C Process for producing nucleic acid inhibiting protein by inducing and cultivating trichoid root of Chinese trichosanthes |
| 11/05/2003 | CN1126759C Oligopeptide compounds containing D-2-alkyltryptophan capable of promoting release of growth hormone |
| 11/05/2003 | CN1126758C Prepn. of blood coagulation factor IX compound |
| 11/04/2003 | US6642438 Melon promoters for expression of transgenes in plants |
| 11/04/2003 | US6642371 Haemophilus adherence and penetration proteins |
| 11/04/2003 | US6642362 Genes coding proteins for early liver development and their use in diagnosing and treating liver disease |
| 11/04/2003 | US6642361 Polypeptide for use in genration of silk |
| 11/04/2003 | US6642360 Secreted polypeptides that stimulate release of proteoglycans from cartilage |
| 11/04/2003 | US6642359 Peptide or protein for use in the diagnosis, treatment or prophylaxis of viral disease |
| 11/04/2003 | US6642358 Receptor that binds trail |
| 11/04/2003 | US6642357 Process for preparing modified proteins |
| 11/04/2003 | US6642355 Endothelin-antagonizing peptide |
| 11/04/2003 | US6642354 Molecular mimetics of unique Neisseria meningitidis serogroup B epitopes |
| 11/04/2003 | US6642353 Peptide ligands for the erythropoietin receptor |
| 11/04/2003 | US6642203 Purified peptide from penaeid prawns, having specified molecular mass and isoelectric pH, comprising proline-rich N-terminal region and C-terminal region having 6 cysteine residues forming three intramolecular disulfide bridges |
| 11/04/2003 | US6642040 Human cGMP-stimulated cyclic nucleotide phosphodiesterase |
| 11/04/2003 | US6642032 Uses of avian interferon gamma (IFN-γ) |
| 11/04/2003 | US6642030 Gene encoding a polypeptide comprising point mutations which result in amino acid substitutions; transforming cell with vector to produce polypeptide with improved insecticidal activity |
| 11/04/2003 | US6642029 Yeast cells comprising vectors are joined to leader and processing signals which provide for expression and secretion of the gene product; Saccharomyces |
| 11/04/2003 | US6642028 Isolated DNA encoding a Factor VIII protein; consensus splice sites which have been corrected relative to those of given nucleotide sequence |
| 11/04/2003 | US6642026 Method of producing biologically active human acidic fibroblast growth factor and its use in promoting angiogenesis |
| 11/04/2003 | US6642025 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 11/04/2003 | US6642024 Guanylate-binding protein |
| 11/04/2003 | US6642023 High molecular weight; encoded by isolated nucleic acid; expression vectors; use for diagnostics, prophylaxis and treatment of infections |
| 11/04/2003 | US6642022 Polypeptide, encoded by recombinant nucleic acid; antagonists can be used for treatment of atherosclerosis and cancer; use for evaluating new drugs |
| 11/04/2003 | US6642008 Assays and therapies for latent viral infection |
| 11/04/2003 | US6642006 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of nervous system, vision, kidney and liver disorders |
| 11/04/2003 | US6642002 Method of diagnosing pulmonary hypertension |
| 11/04/2003 | US6641997 Tetrameric, two-transmembrane-domain-type bound to a solid support; substituting amino acids to permit binding to agitoxin; use in treating cardiac arrhythmia, diabetes, seizures, asthma and hypertension |
| 11/04/2003 | US6641995 Methods for identifying cell cycle regulators |
| 11/04/2003 | US6641820 Treating a bone tumor, in particular pain associated with bone tumor, by administration to a patient of a therapeutically effective amount of an agent are disclosed. The agent may include a clostridial neurotoxin component attached to target |
| 11/04/2003 | US6641819 Porcine reproductive and respiratory syndrome vaccine, based on isolate JA-142 |
| 11/04/2003 | US6641818 Cellular proteins which mediate herpesvirus entry |
| 11/04/2003 | US6641815 Sequestrin |
| 11/04/2003 | US6641814 Identification and characterization of a number of M. tuberculosis derived novel proteins and protein fragments (SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 17-23, 42, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, and others, polypeptides, |
| 11/04/2003 | US6641813 Methods and reagents for diagnosis of autoantibodies |
| 11/04/2003 | US6641812 Heat shock protein-based vaccines and immunotherapies |
| 11/04/2003 | US6641809 Method of regulating cellular processes mediated by B7 and CD28 |
| 11/04/2003 | US6641807 Helper dependent adenoviral vectors encoding erythropoietin provide high levels of epo to achieve a long-term therapeutically effective dosage, and allow for repeat administration to patients with disorders such as anaemia of |
| 11/04/2003 | CA2085191C Vaccines based on modified type 1 bovine herpesviruses |
| 11/04/2003 | CA2084677C Apo ai polypeptides, antibodies, and immunoassays |
| 11/04/2003 | CA2073616C Use of hpv-16 e6 and e7-gene derived peptides for the diagnostic purpose |
| 11/01/2003 | CA2391438A1 Psp94 diagnostic reagents and assays |
| 11/01/2003 | CA2380662A1 Psp94 diagnostic reagents and assays |
| 10/30/2003 | WO2003089935A1 THE METHOD FOR MEASURING THE AMOUNT OF βiG-H3 PROTEIN AND DIAGNOSTIC KIT USING THE SAME |
| 10/30/2003 | WO2003089934A2 Method for diagnosing inflammatory diseases and infections by the determination of lasp-1/lap-1 |
| 10/30/2003 | WO2003089927A2 Antigens associated with haematological malignancy |
| 10/30/2003 | WO2003089672A1 Hepatitis c virus assay systems |
| 10/30/2003 | WO2003089671A1 'doping' in walk-through mutagenesis |
| 10/30/2003 | WO2003089653A2 Human il-18 crystal structure |
| 10/30/2003 | WO2003089649A1 Expression vector comprising a signal sequence and an amino-terminal peptide tag |
| 10/30/2003 | WO2003089647A1 Xanthomonas genes associated with plant pathogenicity |
| 10/30/2003 | WO2003089646A1 Novel proteins and dnas encoding the same |
| 10/30/2003 | WO2003089645A1 Human cancer suppressor gene, hccs-4 and protein encoded therein |
| 10/30/2003 | WO2003089644A1 Novel proteins and dnas encoding the same |
| 10/30/2003 | WO2003089643A1 Novel proteins and dnas encoding the same |
| 10/30/2003 | WO2003089630A1 Methods for producing immortalised antibodies-secreting cells |
| 10/30/2003 | WO2003089626A1 Transgenic saccharomyces cerevisiae and method for bioremediation |
| 10/30/2003 | WO2003089624A2 Fc receptor homolog, reagents, and uses thereof |
| 10/30/2003 | WO2003089623A2 Genetic marker for endocrine disorders |
| 10/30/2003 | WO2003089622A2 Novel genes, compositions, and methods for modulating the unfolded protein response |
| 10/30/2003 | WO2003089620A2 Phospholipases, nucleic acids encoding them and methods for making and using them |
| 10/30/2003 | WO2003089616A2 Soluble mic polypeptides as markers for diagnosis, prognosis and treatment of cancer and autoimmune diseases or conditions |
| 10/30/2003 | WO2003089615A2 Antiviral inhibitions of capsid proteins |
| 10/30/2003 | WO2003089613A2 Tocopherol associated protein and uses thereof |
| 10/30/2003 | WO2003089612A2 IMPROVED rAAV VECTORS |
| 10/30/2003 | WO2003089608A2 Drg11-responsive (dragon) gene family |
| 10/30/2003 | WO2003089607A2 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them |
| 10/30/2003 | WO2003089603A2 Cytokine receptor |
| 10/30/2003 | WO2003089602A2 Toll-like receptor 11 and toll-like receptor 12 |
| 10/30/2003 | WO2003089596A2 Novel prostate tumor-specific promoter |
| 10/30/2003 | WO2003089595A2 Bivm (basic, immunoglobulin-like variable motif-containing) gene, transcriptional products, and uses thereof |
| 10/30/2003 | WO2003089594A2 A device and methods for concentrating prion protein isoforms |
| 10/30/2003 | WO2003089591A2 Method of production of soluble and functional large eukaryotic proteins |
| 10/30/2003 | WO2003089588A2 Novel molecules of the pyrin/nbs/lrr protein family and uses thereof |
| 10/30/2003 | WO2003089584A2 Use of parapox b2l protein to modify immune responses to administered antigens |
| 10/30/2003 | WO2003089583A2 Tissue specific genes and gene clusters |
| 10/30/2003 | WO2003089582A2 Multimeric ligands with enhanced stability |
| 10/30/2003 | WO2003089580A2 Cancer models |
| 10/30/2003 | WO2003089574A2 Synthetic glyco-lipo-peptides as vaccines |
| 10/30/2003 | WO2003089573A2 Methods of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof |
| 10/30/2003 | WO2003089572A2 Essential and important genes of pseudomonas aeroginosa and the use thereof to design or identify antibacterial agents |
| 10/30/2003 | WO2003089571A2 Ehrlichia canis genes and vaccines |
| 10/30/2003 | WO2003089470A1 Peptides capable of inducing attraction to the axonal growth and their use for treating neurodegenerative diseases |
| 10/30/2003 | WO2003089469A2 Cation channel proteins |
| 10/30/2003 | WO2003089468A1 Methods and means for producing proteins with predetermined post-translational modifications |
| 10/30/2003 | WO2003089467A1 Fragments of apoptin |
| 10/30/2003 | WO2003089466A1 Novel proteins and dnas encoding the same |
| 10/30/2003 | WO2003089465A2 Crystals structure of the mouse apoptosis-inducing factor aif and applications thereof |
| 10/30/2003 | WO2003089464A1 Two green fluorescent protein fragments and their use in a method for detecting protein - protein interactions |
| 10/30/2003 | WO2003089460A1 Immunological methods and compositions for the treatment of alzheimer's disease |
| 10/30/2003 | WO2003089458A2 Conjugates of membrane translocating agents and pharmaceutically active agents |
| 10/30/2003 | WO2003089455A2 Low-cost production of peptides |
| 10/30/2003 | WO2003089454A2 Unnatural amino acid containing display libraries |
| 10/30/2003 | WO2003089452A2 Compositions and methods for regulation of plant gamma-tocopherol methyltransferase |
| 10/30/2003 | WO2003089450A2 Fusion polypeptides and methods for inhibiting microbial adhesion |
| 10/30/2003 | WO2003089011A1 rAAV VECTOR-BASED COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF MAMMALIAN DISEASES |
| 10/30/2003 | WO2003088996A2 Lewis y epitope modified polypeptide, or mucin fusion polypetide, tumor vaccines |
| 10/30/2003 | WO2003088995A2 Mucin fusion polypeptide vaccines, compositions and methods of use thereof |
| 10/30/2003 | WO2003088979A2 Oligonucleotides from sequences coding for the surface component of envelope proteins of primate t-cell leukaemia/lymphoma viruses (ptlv) and uses thereof |